References
- Inui T, Kumagaya S, Myowa-Yamakoshi M. Neurodevelopmental hypothesis about the etiology of autism spectrum disorders. Front Hum Neurosci. 2017;11(July):354.
- Rossignol DA, Frye RE. Mitochondrial dysfunction in autism spectrum disorders: a systematic review and meta-analysis. Mol Psychiatry. 2012;17(3):290–314.
- Siddiqui MF, Elwell C, Johnson MH. Mitochondrial dysfunction in autism spectrum disorders. Autism Open Access. 2016;6(4):1000190.
- Giulivi C, Zhang Y-F, Omanska-Klusek A, et al. Mitochondrial dysfunction in autism. JAMA. 2010;304(21):2389–2396.
- Rose S, Frye RE, Slattery J, et al. Oxidative stress induces mitochondrial dysfunction in a subset of autistic lymphoblastoid cell lines. Transl Psychiatry. 2014;4(4):e377.
- Antony PMA, Boyd O, Trefois C, et al. Platelet mitochondrial membrane potential in parkinson’s disease. Ann Clin Transl Neurol. 2015;2(1):67–73.
- Bosetti F, Brizzi F, Barogi S, et al. Cytochrome c oxidase and mitochondrial F1F0-ATPase (ATP synthase) activities in platelets and brain from patients with Alzheimer's disease. Neurobiol Aging. 2002;23(3):371–376.
- Sangiorgi S, Mochi M, Riva R, et al. Abnormal platelet mitochondrial function in patients affected by migraine with and without aura. Cephalalgia. 1994;14(1):21–23.
- Ben-Shachar D, Bonne O, Chisin R, et al. Cerebral glucose utilization and platelet mitochondrial complex I activity in schizophrenia: a FDG-PET Study. Prog Neuro-Psychopharmacol Biol Psychiatry. 2007;31(4):807–813.
- Parker WD, Boyson SJ, Luder AS, et al. Evidence for a defect in NADH: ubiquinone oxidoreductase (complex I) in huntington’s disease. Neurology. 1990;40(8):1231–1234.
- Bijl N, Thys C, Wittevrongel C, et al. Platelet studies in autism spectrum disorder patients and first-degree relatives. Molecular Autism. 2015;6(1):1–10.
- Onore C, Careaga M, Ashwood P. The role of immune dysfunction in the pathophysiology of autism. Brain Behav Immun. 2012;26(3):383–392.
- Enstrom AM, Onore CE, Van de Water JA, et al. Differential monocyte responses to TLR ligands in children with autism spectrum disorders. Brain Behav Immun. 2010;24(1):64–71.
- Jyonouchi H, Sun S, Le H. Proinflammatory and regulatory cytokine production associated with innate and adaptive immune responses in children with autism spectrum disorders and developmental regression. J Neuroimmunol. 2001;120(1-2):170–179.
- Ashwood P, Krakowiak P, Hertz-Picciotto I, et al. Altered T cell responses in children with autism. Brain Behav Immun. 2011;25(5):840–849.
- Stubbs EG, Crawford ML. Depressed lymphocyte responsiveness in autistic children. J Autism Child Schizophr. 1977;7(1):49–55.
- Napoli E, Wong S, Hertz-Picciotto I, et al. Deficits in bioenergetics and impaired immune response in granulocytes from children with autism. Pediatrics. 2014;133(5):e1405–10.
- Rossignol DA, Bradstreet JJ, Van Dyke K, et al. Hyperbaric oxygen treatment in autism spectrum disorders. Med Gas Res. 2012;2(1):16.
- Ghanizadeh A. Hyperbaric oxygen therapy for treatment of children with autism: a systematic review of randomized trials. Med Gas Res. 2012;2(1):13.
- Rossignol DA, Rossignol LW, James SJ, et al. The effects of hyperbaric oxygen therapy on oxidative stress, inflammation, and symptoms in children with autism: an open-label pilot study. BMC Pediatr. 2007;7(1):36.
- Abdel-Rahman EA, Mahmoud AM, Aaliya A, et al. Resolving contributions of oxygen-consuming and ROS-generating enzymes at the synapse. Oxid Med Cell Longevity. 2016;2016:1–7.
- Geier DA, Kern JK, Geier MR. A comparison of the autism treatment evaluation checklist (ATEC) and the childhood autism rating scale (CARS) for the quantitative evaluation of autism. J Ment Health Res Intellect Disabil. 2013;6(4):255–267.
- Rickham PP. Human experimentation. Code of ethics of the world medical association. Declaration of helsinkI. Br Med J. 1964;2(5402):177.
- Bhutani S, Vishwanath G. Hyperbaric oxygen and wound healing. Indian J Plast Surg. 2012;45(2):316–324.
- Chlebowski C, Green JA, Barton ML, et al. Using the childhood autism rating scale to diagnose autism spectrum disorders. J Autism Dev Disord.2013;40(7):787–799.
- Mahapatra S, Vyshedskiy D, Martinez S, et al. Autism treatment evaluation checklist (ATEC) norms: a ‘growth chart’ for ATEC score changes as a function of age. Children (Basel). 2018;5(2):25.
- Mazefsky CA, Williams DL, Minshew NJ. Variability in adaptive behavior in autism: evidence for the importance of family history. J Abnorm Child Psychol. 2008; 36(4):591–599.
- Fenton G, D'ardia C, Valente D, et al. Vineland adaptive behavior profiles in children with autism and moderate to severe developmental delay. Autism. 2003;7(3):269–287.
- Sjövall F, Ehinger JKH, Marelsson SE, et al. Mitochondrial respiration in human viable platelets-methodology and influence of gender, age and storage. Mitochondrion. 2013;13(1):7–14.
- Oh H, Siano B, Diamond S. Neutrophil isolation protocol. J Vis Exp. 2008;(17):e745:1–2.
- Rodak BF, Fritsma GA, Doig K. 2007. Hematology: clinical principles and applications. Philadelphia (PA): Saunders Elsevier.
- Altenhöfer S, Radermacher KA, Kleikers PWM, et al. Evolution of NADPH oxidase inhibitors: selectivity and mechanisms for target engagement. Antioxid Redox Signal. 2015;23(5):406–427.
- Jung Y, Lee AM, McKee SA, et al. Maternal smoking and autism spectrum disorder: meta-analysis with population smoking metrics as moderators. Sci Rep. 2017;7(1):4315.
- Panday A, Sahoo MK, Osorio D, et al. NADPH oxidases: an overview from structure to innate immunity-associated pathologies. Cell Mol Immunol. 2015;12(1):5–23.
- Delbarba A, Abate G, Prandelli C, et al. Mitochondrial alterations in peripheral mononuclear blood cells from alzheimer's disease and mild cognitive impairment patients. Oxid Med Cell Longev. 2016;2016(January):5923938–5923911.
- Donato SD. Multisystem manifestations of mitochondrial disorders. J Neurol. 2009;256(5):693–710.
- Li Y, Aurelio MD, Deng J-h, et al. An assembled complex IV maintains the stability and activity of complex I in mammalian mitochondria. J Biol Chem. 2007;282(24):17557–17562.
- Stroud DA, Maher MJ, Lindau C, et al. COA6 is a mitochondrial complex IV assembly factor critical for biogenesis of mtDNA-encoded COX2. Hum Mol Genet. 2015;24(19):5404–5415.
- Fernández-Vizarra E, Enríquez JA, Pérez-Martos A, et al. Tissue-specific differences in mitochondrial activity and biogenesis. Mitochondrion. 2011;11(1):207–213.
- Herbers E, Kekäläinen NJ, Hangas A, et al. Tissue specific differences in mitochondrial DNA maintenance and expression. Mitochondrion. 2019;44:85–92.
- Rose S, Niyazov DM, Rossignol DA, et al. Clinical and molecular characteristics of mitochondrial dysfunction in autism spectrum disorder. Mol Diagn Ther. 2018;22(5):571–593.
- Arnoult D, Soares F, Tattoli I, et al. Mitochondria in innate immunity. EMBO Rep. 2011;12(9):901–910.
- Belle JEL, Sperry J, Ngo A, et al. Maternal inflammation contributes to brain overgrowth and autism-associated behaviors through altered redox signaling in stem and progenitor cells. Stem Cell Reports. 2014;3(5):725–734.
- Nadeem A, Ahmad SF, Bakheet SA, et al. Toll-like receptor 4 signaling is associated with upregulated NADPH oxidase expression in peripheral T cells of children with autism. Brain Behav Immun. 2017;61:146–154.
- Kurt B, Kurt Y, Karslioğlu Y, et al. Effects of hyperbaric oxygen on energy production and xanthine oxidase levels in striated muscle tissue of healthy rats. J Clin Neurosci. 2008;15(4):445–450.
- Gutsaeva DR, Suliman HB, Carraway MS, et al. Oxygen-induced mitochondrial biogenesis in the rat hippocampus. Neuroscience. 2006;137(2):493–504.
- Rockswold SB, Rockswold GL, Zaun DA, et al. A prospective, randomized clinical trial to compare the effect of hyperbaric to normobaric hyperoxia on cerebral metabolism, intracranial pressure, and oxygen toxicity in severe traumatic brain injury. JNS. 2010;112(5):1080–1094.
- Mukaka MM. Statistics corner: a guide to appropriate use of correlation coefficient in medical research. Malawi Medical Journal: The Journal of Medical Association of Malawi. 2012;24(3):69–71.